Concepedia

Zhicai Lin

ZL

Statistics

Publications

5

Citations

143

H-Index

5

Active since

2013

Affiliations

Shanghai Cell Therapy Research Institute(Current)

Shanghai University

Xiamen University

Zhicai Lin is an author at Shanghai Cell Therapy Research Institute specializing in oncology, immunology, and immunotherapy.

Publications per year

2013–2022

5

Publications

5

Increased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma.

Jing Gao, Zhengzhi Zou, Jing Gao et al. · PubMed · 2015 · 57 citations

Medicine, Molecular Biology, Oncology +17

αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib

Juemin Fang, Na Ding, Xianling Guo et al. · Journal for ImmunoTherapy of Cancer · 2021 · 46 citations · Full text

Medicine, Immunology, Oncology +17

PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report

Chenggong Li, Yan Sun, Jing Wang et al. · Frontiers in Immunology · 2021 · 15 citations · Full text

Life Sciences, Immunology, Oncology +16

Evaluation of Nonviral piggyBac and lentiviral Vector in Functions of CD19chimeric Antigen Receptor T Cells and Their Antitumor Activity for CD19+ Tumor Cells

Zhicai Lin, Xiangzhen Liu, Tao Liu et al. · Frontiers in Immunology · 2022 · 15 citations · Full text

Life Sciences, Immunology, Oncology +15

A Suppressor of Cytokine Signaling 1 Antagonist Enhances Antigen-Presenting Capacity and Tumor Cell Antigen-Specific Cytotoxic T Lymphocyte Responses by Human Monocyte-Derived Dendritic Cells

Yongjun Wang, Shengyu Wang, Yuan Ding et al. · Clinical and Vaccine Immunology · 2013 · 10 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 5